Jafron Biomedical Co.,Ltd. (SHE:300529)
China · Delayed Price · Currency is CNY 23.74
+0.27 (1.15%)
Sep 5, 2025, 3:04 PM CST
Jafron Biomedical Market Cap
Jafron Biomedical has a market cap or net worth of 18.38 billion as of September 5, 2025. Its market cap has decreased by -7.98% in one year.
Market Cap
18.38B
Enterprise Value
17.59B
Revenue
2.32B
Ranking
n/a
PE Ratio
27.90
Stock Price
23.74
Market Cap Chart
Since August 2, 2016, Jafron Biomedical's market cap has increased from 6.41B to 18.38B, an increase of 186.94%. That is a compound annual growth rate of 12.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 18.38B | -19.09% |
| Dec 31, 2024 | 22.72B | 27.96% |
| Dec 29, 2023 | 17.76B | -28.23% |
| Dec 30, 2022 | 24.74B | -42.00% |
| Dec 31, 2021 | 42.65B | -21.30% |
| Dec 31, 2020 | 54.20B | 80.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Aug 2, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 482.35B |
| WuXi AppTec | 313.22B |
| Shenzhen Mindray Bio-Medical Electronics | 287.79B |
| Sichuan Biokin Pharmaceutical | 155.60B |
| Zhangzhou Pientzehuang Pharmaceutical., | 123.00B |
| Aier Eye Hospital Group | 120.10B |
| Shanghai United Imaging Healthcare | 116.97B |
| Yunnan Baiyao Group Co.,Ltd | 105.81B |